Union européenne - danois - EMA (European Medicines Agency)

bayer ag - darolutamide - prostatic neoplasmer, kastration-resistent - endokrine terapi - nubeqa is indicated for the treatment of adult men with- non metastatic castration resistant prostate cancer (nmcrpc) who are at high risk of developing metastatic disease (see section 5. - metastatic hormone sensitive prostate cancer (mhspc) in combination with docetaxel and androgen deprivation therapy (see section 5.

Danemark - danois - Lægemiddelstyrelsen (Danish Medicines Agency)

ever valinject gmbh - dexmedetomidinhydrochlorid - koncentrat til infusionsvæske, opløsning - 100 mikrogram/ml

Danemark - danois - Lægemiddelstyrelsen (Danish Medicines Agency)

europharma.dk aps - carbamazepin - depottabletter - 400 mg

Union européenne - danois - EMA (European Medicines Agency)

mylan pharmaceuticals limited - darunavir - hiv infektioner - antivirale midler til systemisk anvendelse - darunavir, co-administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of patients with human immunodeficiency virus (hiv-1) infection (see section 4. darunavir mylan 75 mg, 150 mg, 300 mg and 600 mg tablets may be used to provide suitable dose regimens (see section 4. 2):til behandling af hiv-1 infektion i antiretroviral behandling (art)-erfarne voksne patienter, herunder dem, der har været meget forbehandlet. til behandling af hiv-1 infektion hos pædiatriske patienter fra en alder af 3 år og mindst 15 kg kropsvægt. i beslutter at indlede behandling med darunavir co-administreres med en lav dosis ritonavir, forsigtig, bør det overvejes, om den historie behandling af den enkelte patient og de mønstre af mutationer, der er forbundet med forskellige agenter. genotypic or phenotypic testing (when available) and treatment history should guide the use of darunavir (see sections 4. 2, 4. 4 og 5. darunavir co-administreres med en lav dosis ritonavir er indiceret i kombination med andre antiretrovirale lægemidler til behandling af patienter med human immundefekt virus (hiv-1) infektion.  darunavir co-administered with cobicistat is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv-1) infection in adults and adolescents (aged 12 years and older, weighing at least 40 kg) (see section 4.  darunavir mylan 400 mg and 800 mg tablets may be used to provide suitable dose regimens for the treatment of hiv-1 infection in adult and paediatric patients from the age of 3 years and at least 40 kg body weight who are: antiretroviral therapy (art)-naïve (see section 4.  art-experienced with no darunavir resistance associated mutations (drv-rams) and who have plasma hiv-1 rna < 100,000 copies/ml and cd4+ cell count ≥ 100 cells x 10⁶/l. i beslutter at indlede behandling med darunavir i en sådan kunst-erfarne patienter, genotypiske test bør vejlede i brugen af darunavir (se afsnit 4. 2, 4. 3, 4. 4 og 5.

Danemark - danois - Lægemiddelstyrelsen (Danish Medicines Agency)

pharmathen s.a. - darunavirpropylenglycolat - filmovertrukne tabletter - 150 mg

Danemark - danois - Lægemiddelstyrelsen (Danish Medicines Agency)

pharmathen s.a. - darunavirpropylenglycolat - filmovertrukne tabletter - 300 mg

Danemark - danois - Lægemiddelstyrelsen (Danish Medicines Agency)

pharmathen s.a. - darunavirpropylenglycolat - filmovertrukne tabletter - 600 mg

Union européenne - danois - EMA (European Medicines Agency)

jenson pharmaceutical services limited - dextromethorphan, quinidin - neurobehavioral manifestations - andre narkotika stoffer - nuedexta er indiceret til symptomatisk behandling af pseudobulbar påvirkning (pba) hos voksne. effekt er kun undersøgt hos patienter med underliggende amyotrofisk lateralsklerose eller multipel sklerose.

Union européenne - danois - EMA (European Medicines Agency)

ferring pharmaceuticals a/s - follitropin delta - anovulation - køn hormoner og modulatorer af den genitale system, - kontrolleret ovariestimulation for udviklingen af flere follikler hos kvinder undergår assisterede reproduktive teknologier (art) som en in vitro-befrugtning (ivf) eller intracytoplasmatisk sperm injektion (icsi) cyklus.

Danemark - danois - Lægemiddelstyrelsen (Danish Medicines Agency)

bluefish pharmaceuticals ab - ondansetron - smeltetabletter - 8 mg